ClassID:

20918

A61K38/1709 - page 9 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#2401
20170128530
2017-05-11

MODIFIED PROCEDURE FOR CONTROLLED OVARIAN STIMULATION AND INTRAUTERINE INSEMINATION

#2402
20170128529
2017-05-11

CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION

#2403
20170128528
2017-05-11

Modified Friedreich ataxia genes and vectors for gene therapy

#2404
20170128527
2017-05-11

PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA

#2405
20170128526
2017-05-11

STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS

#2406
20170128520
2017-05-11

Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators

#2407
20170121401
2017-05-04

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

#2408
20170121380
2017-05-04

Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog

#2409
20170119848
2017-05-04

Composition and method for the treatment or prevention of spinal disorders

#2410
20170119827
2017-05-04

Method of reducing the likelihood of skin cancer in an individual human being

#2411
20170119682
2017-05-04

MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES

#2412
20170114412
2017-04-27

Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2

#2413
20170114109
2017-04-27

Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target

#2414
20170112900
2017-04-27

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#2415
20170112899
2017-04-27

Polypeptide-polymer conjugates and methods of use thereof

#2416
20170107270
2017-04-20

Constructs having a SIRP-α domain or variant thereof

#2417
20170107265
2017-04-20

Met e 1 tropomyosin variants for use in allergen-specific immunotherapy

#2418
20170106053
2017-04-20

ACTH prophylactic treatment of renal disorders

#2419
20170106008
2017-04-20

STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases

#2420
20170100490
2017-04-13

Prodrug Comprising a Drug Linker Conjugate

#2421
20170100458
2017-04-13

Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity

#2422
20170100457
2017-04-13

Immediate-release tablet formulation, composition for tablets and method for manufacturing immediate-release tablet formulation

#2423
20170100456
2017-04-13

Methods and compositions for immunomodulation

#2424
20170100455
2017-04-13

USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY

#2425
20170095503
2017-04-06

Inhibition of endosomal toll-like receptor activation

#2426
20170088857
2017-03-30

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

#2427
20170088602
2017-03-30

Fibronectin based scaffold domain proteins that bind to myostatin

#2428
20170088594
2017-03-30

Glycoproteins having lipid mobilizing properties and therapeutic uses thereof

#2429
20170088593
2017-03-30

Delivery of Nrf2 as therapy for protection against reactive oxygen species

#2430
20170087254
2017-03-30

Endogenous neogenesis of beta cells

#2431
20170087212
2017-03-30

Gene therapy for neurodegenerative disorders

#2432
20170087211
2017-03-30

Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient

#2433
20170081679
2017-03-23

METHODS OF IMPROVING NUCLEASE MEDIATED HOMOLOGOUS RECOMBINATION

#2434
20170081377
2017-03-23

RTEF-1 variants and the use thereof for inhibition of angiogenesis

#2435
20170080060
2017-03-23

Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide

#2436
20170080053
2017-03-23

REGULATION OF SODIUM CHANNELS BY PLUNC PROTEINS

#2437
20170080052
2017-03-23

Method of treating fulminant hepatic failure using DLL4 cytokine

#2438
20170080047
2017-03-23

Compositions and methods for modulating the immune system

#2439
20170079935
2017-03-23

Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)

#2440
20170079920
2017-03-23

Technology for the Preparation of Microparticles

#2441
20170079909
2017-03-23

Hydrogel toxin-absorbing or binding nanoparticles

#2442
20170073384
2017-03-16

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#2443
20170072031
2017-03-16

Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same

#2444
20170072011
2017-03-16

Methods of treatment using hemopexin compositions

#2445
20170065674
2017-03-09

Method of promoting wound healing with hyodxia-induced mitogenic factor

#2446
20170065673
2017-03-09

NANOPARTICLE AGGREGATES CONTAINING OSTEOPONTIN AND CALCIUM- AND/OR STRONTIUM-CONTAINING PARTICLES

#2447
20170058349
2017-03-02

METHODS FOR MANAGING CARE OF PATIENTS PREDISPOSED TO PROGRESSIVE MITRAL VALVE DISEASES

#2448
20170058258
2017-03-02

Composition for inducing direct transdifferentiation into oligodendrocyte progenitor cells from somatic cells and use thereof

#2449
20170056556
2017-03-02

Enhancement of osteogenic potential of bone grafts

#2450
20170056534
2017-03-02

Detecting a therapeutic cell

#2451
20170056470
2017-03-02

Peptides of syndecan-1 for inhibiting angiogenesis

#2452
20170049936
2017-02-23

Implants having a drug load of an oxysterol and methods of use

#2453
20170049929
2017-02-23

Natural tissue scaffolds as tissue fillers

#2454
20170049858
2017-02-23

Stable formulations for parenteral injection of peptide drugs

#2455
20170049854
2017-02-23

Methods for treating myocardial infarction comprising administering sonic hedgehog

#2456
20170049853
2017-02-23

Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

#2457
20170044248
2017-02-16

Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

#2458
20170043023
2017-02-16

Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction

#2459
20170043002
2017-02-16

Methods and compositions relating to P62 for the treatment and prophylaxis of cancer

#2460
20170042973
2017-02-16

Compositions and methods for modulating stem cells and uses thereof

#2461
20170042971
2017-02-16

Stable MIA/CD-RAP formulation

#2462
20170042970
2017-02-16

Use of peptide for treating angiogenesis-related diseases

#2463
20170042969
2017-02-16

Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity

#2464
20170042968
2017-02-16

Isoform nell-1 peptide

#2465
20170042842
2017-02-16

Sensorineural hair cell differentiation

#2466
20170037091
2017-02-09

STY PEPTIDES FOR INHIBITION OF ANGIOGENESIS

#2467
20170035844
2017-02-09

Biomarkers for painful intervertebral discs and methods of use thereof

#2468
20170035843
2017-02-09

COMPOSITION TO REPURPOSE DRUGS

#2469
20170035842
2017-02-09

Apolipoprotein O and fragments thereof for inducing apoptosis in a cancerous cell

#2470
20170035841
2017-02-09

Treatment of myotonic dystrophy

#2471
20170035840
2017-02-09

Liquid enteral nutritional composition with a low monovalent metal ion content

#2472
20170035839
2017-02-09

Methods and compositions for treating Huntington's Disease

#2473
20170035690
2017-02-09

Bioerodible silicon-based devices for delivery of therapeutic agents

#2474
20170028034
2017-02-02

Mutant huntingtin-mediated protein dysfunction

#2475
20170028023
2017-02-02

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

#2476
20170028019
2017-02-02

Suppression of allergic lung inflammation and hyperreactivity

#2477
20170022274
2017-01-26

T-cell redirecting bispecific antibodies for treatment of disease

#2478
20170021065
2017-01-26

Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods

#2479
20170020163
2017-01-26

METHODS AND COMPOSITIONS USING FRESH OR FROZEN MEAT TO IMPROVE FOOD EFFICIENCY IN ANIMALS SUCH AS DOGS

#2480
20170015717
2017-01-19

Methods and compositions comprising tau oligomers

#2481
20170014494
2017-01-19

Sumoylation of SERCA2a and cardiovascular disease

#2482
20170014480
2017-01-19

Peptides derived from NCAPG2 and their use

#2483
20170014479
2017-01-19

Therapeutic applications of Smad7

#2484
20170014478
2017-01-19

NEURONAL VIABILITY FACTOR AND USE THEREOF

#2485
20170014477
2017-01-19

FREE RAPTOR REDUCES AGING- AND OBESITY-INDUCED FATTY LIVER

#2486
20170007739
2017-01-12

Implants having a high drug load of an oxysterol and methods of use

#2487
20170007720
2017-01-12

METHODS AND COMPOSITIONS FOR GENE DELIVERY TO ON BIPOLAR CELLS

#2488
20170007708
2017-01-12

Glycotargeting therapeutics

#2489
20170007678
2017-01-12

Compositions and methods to promote wound healing

#2490
20170007669
2017-01-12

PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#2491
20170007645
2017-01-12

Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

#2492
20170007606
2017-01-12

FGFR inhibitor for use in the treatment of hypophosphatemic disorders

#2493
20170002413
2017-01-05

MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG

#2494
20170000865
2017-01-05

DNA vaccines encoding heat shock proteins

#2495
20170000857
2017-01-05

Target for diabetes treatment and prevention

#2496
20170000849
2017-01-05

CD300A RECEPTORS AS VIRUS ENTRY COFACTORS

#2497
20170000847
2017-01-05

HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD

#2498
20170000815
2017-01-05

LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENE

#2499
20170000746
2017-01-05

METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONS

#2500
20160376337
2016-12-29

Peptides and compositions for treatment of joint damage

#2501
20160376333
2016-12-29

Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins

#2502
20160376323
2016-12-29

Adeno-associated virus virions with variant capsid and methods of use thereof

#2503
20160375151
2016-12-29

Adeno-associated virus virions with variant capsid and methods of use thereof

#2504
20160369243
2016-12-22

RNA preparations comprising purified modified RNA for reprogramming cells

#2505
20160368956
2016-12-22

Method of preventively treating a subject at the risk of developing infections of a respiratory virus

#2506
20160368955
2016-12-22

Compound, use, anti-tumor pharmaceutical composition, gene construct for polypeptide expression, process for the production, process for the evaluation of tumor cells, method of sensitization of tumor cells to chemotherapeutic

#2507
20160368954
2016-12-22

Methods for treating disorders that involve immunoglobulin A

#2508
20160368930
2016-12-22

Compositions and methods for treating cancer

#2509
20160367664
2016-12-22

Method of treating cancer using IL2R beta/common gamma chain antibodies

#2510
20160367630
2016-12-22

Modulation of cellular localization of cyclin C

#2511
20160367629
2016-12-22

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

#2512
20160362492
2016-12-15

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#2513
20160362462
2016-12-15

Modification and compositions of human secretoglobin proteins

#2514
20160361437
2016-12-15

Treatment of retinal degeneration using gene therapy

#2515
20160361385
2016-12-15

METHOD FOR TREATING ALZHEIMER'S DISEASE USING SUPERIOR STABILITY TUBULIN CONSRUCTS

#2516
20160361384
2016-12-15

COSMETIC USE OF DERMICIDIN, OR ANALOGUES OR FRAGMENTS THEREOF, FOR THE PREVENTION AND/OR TREATMENT AND DIAGNOSIS OF OILY SKIN AND AESTHETIC SKIN DISORDERS ASSOCIATED THEREWITH

#2517
20160361383
2016-12-15

Liquid nutritional formula for tyrosinemia patients

#2518
20160355559
2016-12-08

Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema

#2519
20160354437
2016-12-08

COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE RESPONSE

#2520
20160354436
2016-12-08

Compositions and Formulations for Increasing Renal Function and Treatment and Prevention of Renal Diseases, and Methods of Production and Use Thereof

#2521
20160354435
2016-12-08

Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema

#2522
20160354333
2016-12-08

COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS AND METHODS OF USE THEREOF

#2523
20160349260
2016-12-01

Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)

#2524
20160346391
2016-12-01

Compositions and methods to modulate cell activity

#2525
20160346351
2016-12-01

Targeted oesophageal administration of ZN-α-glycoproteins (ZAG), methods and formulations thereof

#2526
20160346350
2016-12-01

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A BONE CONDITION

#2527
20160346349
2016-12-01

PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION

#2528
20160340744
2016-11-24

miR-211 expression and related pathways in human melanoma

#2529
20160340402
2016-11-24

FKBP-L polypeptides and uses in angiogenesis-mediated disorders

#2530
20160339079
2016-11-24

TRANSMUCOSAL AND TRANSEPITHELIAL DRUG DELIVERY SYSTEM

#2531
20160339078
2016-11-24

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

#2532
20160334421
2016-11-17

Method of diagnosis, prognostic or treatment of neurodegenerative disease

#2533
20160333093
2016-11-17

Targeted therapy for small cell lung cancer

#2534
20160331839
2016-11-17

METHOD FOR INCREASING THE BIOAVAILABILITY OF INHALED COMPOUNDS

#2535
20160331806
2016-11-17

Application of YB-1 protein and fragments thereof for preparing medicinal agents in treating alzheimer's disease

#2536
20160331804
2016-11-17

Selectively targeted antimicrobial peptides and the use thereof

#2537
20160331726
2016-11-17

Treatment and diagnosis of melanoma

#2538
20160331683
2016-11-17

WATER-IN-OIL TYPE EMULSION FOR TREATING A DISEASE OF THE EYE

#2539
20160326250
2016-11-10

Methods, kits and devices for promoting cardiac regeneration

#2540
20160326231
2016-11-10

Inhibitor targeting specific complement system, and preparation method and use thereof

#2541
20160326228
2016-11-10

Isolated nucleotide sequences encoding GDF traps

#2542
20160326225
2016-11-10

Anti-tumor properties of Dickkopf 3b

#2543
20160324975
2016-11-10

Reversible pegylated drugs

#2544
20160324925
2016-11-10

METHODS AND APPARATUS FOR CREATING PARTICLE DERIVATIVES OF HDL WITH REDUCED LIPID CONTENT

#2545
20160324924
2016-11-10

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

#2546
20160324923
2016-11-10

Apolipoprotein A-I mimics

#2547
20160324922
2016-11-10

Beta-casein A2 and blood glucose levels

#2548
20160324921
2016-11-10

TREATMENT OF EYE DISEASE

#2549
20160324915
2016-11-10

Casein peptide for use in the treatment of uterine infections

#2550
20160324883
2016-11-10

Cationic polymers as co-drugs for chemotherapeutic agents

#2551
20160319000
2016-11-03

DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF

#2552
20160317616
2016-11-03

Pharmaceutical compositions targeting WNT pathway proteins

#2553
20160317615
2016-11-03

T CELL MODULATOR

#2554
20160317614
2016-11-03

Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof

#2555
20160312293
2016-10-27

Method of predicting a response to an anti-tumor treatment

#2556
20160312226
2016-10-27

Reduction of lipase activity in product formulations

#2557
20160311934
2016-10-27

HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS

#2558
20160311889
2016-10-27

Removal of serine proteases by treatment with finely divided silicon dioxide

#2559
20160311886
2016-10-27

Constructs Binding to Phosphatidylserine and Their Use in Disease Treatment and Imaging

#2560
20160310618
2016-10-27

Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject

#2561
20160310569
2016-10-27

TUSC2 THERAPIES

#2562
20160310568
2016-10-27

Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions

#2563
20160310567
2016-10-27

COMPOSITIONS FOR INHIBITING VIRAL REPLICATION AND METHODS OF USE AND PRODUCTION THEREOF

#2564
20160310566
2016-10-27

Treatment of gum diseases and gum disorders with TSG-6 protein

#2565
20160310565
2016-10-27

COMPOSITIONS AND METHOD FOR CONTROLLING INFECTIONS IN NON-HUMAN MAMMALS USING ACUTE PHASE PROTEINS

#2566
20160310424
2016-10-27

Wnt compositions and methods for purification

#2567
20160304572
2016-10-20

Recombinant lubricin composition

#2568
20160303200
2016-10-20

Pharmaceutical compositions and methods for the treatment of metastatic cancer

#2569
20160303193
2016-10-20

Inhibition of collagen synthesis

#2570
20160303052
2016-10-20

Modular particles for immunotherapy

#2571
20160297868
2016-10-13

Composition and method for therapeutic agent delivery during pregnancy

#2572
20160296598
2016-10-13

Application of irisin in myocardial ischemia reperfusion

#2573
20160295896
2016-10-13

Liquid milk fortifier composition with relatively high lipid content

#2574
20160289320
2016-10-06

METHOD FOR MODULATING APPETITE

#2575
20160289283
2016-10-06

Selective PYY compounds and uses thereof

#2576
20160289272
2016-10-06

Antimicrobial agents and their use in therapy

#2577
20160287713
2016-10-06

Modified therapeutic agents and compositions thereof

#2578
20160280775
2016-09-29

Treatment for dupuytren's disease

#2579
20160280747
2016-09-29

ANTICALINS

#2580
20160279265
2016-09-29

Methods and compositions for inhibiting oxidative stress

#2581
20160279212
2016-09-29

Annexin II variant compositions and methods

#2582
20160279198
2016-09-29

Suppression of cellular transformation and dysplasia by topical application of lefty

#2583
20160279194
2016-09-29

Histatin for corneal wound healing and ocular surface disease

#2584
20160279193
2016-09-29

Immunosuppressive agents and their use in therapy

#2585
20160273001
2016-09-22

Transduction buffer

#2586
20160271234
2016-09-22

TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONS

#2587
20160271229
2016-09-22

Methods for treating hepatitis C virus infectious disease

#2588
20160271214
2016-09-22

Methods of treating heart failure with agonists of hypocretin receptor 2

#2589
20160271213
2016-09-22

Reelin rescues cognitive function

#2590
20160271212
2016-09-22

Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use

#2591
20160271186
2016-09-22

Compositions comprising perivascular stem cells and nell-1 protein

#2592
20160263233
2016-09-15

Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming

#2593
20160263217
2016-09-15

PROTEIN-SPECIFIC FORMULATIONS

#2594
20160263195
2016-09-15

Compositions and methods for protecting the kidney from ischemia reperfusion injury

#2595
20160263188
2016-09-15

Methods of using myelin basis protein peptide compositions

#2596
20160263187
2016-09-15

Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same

#2597
20160263186
2016-09-15

PIF-TRANSFECTED CELLS AND METHODS OF USE

#2598
20160263185
2016-09-15

Modified binding proteins inhibiting the VEGF-A receptor interaction

#2599
20160263184
2016-09-15

METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1

#2600
20160263182
2016-09-15

Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof

#2601
20160263096
2016-09-15

Use of Hsp70 as a regulator of enzymatic activity

#2602
20160257937
2016-09-08

HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS)

#2603
20160257735
2016-09-08

REGULATION OF NPVF GENE AND ITS PRODUCTS: A METHOD FOR MODULATING ENERGY IMBALANCE

#2604
20160256526
2016-09-08

Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins

#2605
20160256525
2016-09-08

Muteins of tear lipocalin and methods for obtaining the same

#2606
20160252530
2016-09-01

Methods for treating spinocerebellar ataxia type I using RPA1

#2607
20160251693
2016-09-01

Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins

#2608
20160250288
2016-09-01

Nerve regenerating or nerve growth-promoting pharmaceutical composition containing Vax protein as active ingredient

#2609
20160250286
2016-09-01

Control of rheological properties of mixed hyaluronate/lubricin solutions

#2610
20160250285
2016-09-01

NEUROPROTECTIVE PEPTIDES

#2611
20160244524
2016-08-25

Combination immunotherapy for the treatment of cancer

#2612
20160244491
2016-08-25

Peptides and compositions for treatment of joint damage

#2613
20160243276
2016-08-25

Bioerodible silicon-based devices for delivery of therapeutic agents

#2614
20160243193
2016-08-25

METHODS AND COMPOSITIONS FOR THE REDUCTION OF NEUTROPHIL INFLUX AND THE TREATMENT OF BRONCHOPULMONARY DISPLASIA, RESPIRATORY DISTRESS SYNDROME, CHRONIC LUNG DISEASE, PULMONARY FIBROSIS, ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#2615
20160243170
2016-08-25

Compositions and methods for restoring or rejuvenating stem/progenitor cell function

#2616
20160243027
2016-08-25

Implantable solid dosage form

#2617
20160237500
2016-08-18

RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders

#2618
20160237129
2016-08-18

Mitochondrial targeting and therapeutic use thereof

#2619
20160235859
2016-08-18

Methods for DNA-dependent targeting of a cell permeant antibody

#2620
20160235812
2016-08-18

Methods for treating fibrotic cancers

#2621
20160235811
2016-08-18

Compounds and methods for the treatment of vascular disease

#2622
20160235810
2016-08-18

METHODS OF TREATING DIABETES AND RELATED DISORDERS

#2623
20160235809
2016-08-18

Compositions for treating dry eye disease

#2624
20160235675
2016-08-18

Technology for the Preparation of Microparticles

#2625
20160230171
2016-08-11

Methods for inducing glucose uptake

#2626
20160228659
2016-08-11

Dry powder inhaler and system for drug delivery

#2627
20160228505
2016-08-11

Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin

#2628
20160228504
2016-08-11

S100 based treatment of cardiac power failure

#2629
20160228503
2016-08-11

Compositions and Formulations for Prevention and Treatment of Diabetes and Obesity, and Methods of Production and Use Thereof in Glucose and Caloric Control

#2630
20160228502
2016-08-11

Regulating calcium in excitable cells with a novel protein

#2631
20160228501
2016-08-11

Composition for inhibiting human cytomegalovirus replication

#2632
20160228492
2016-08-11

Inhibitors of valosin-containing protein and methods of use

#2633
20160222072
2016-08-04

Universal protein tag for double stranded nucleic acid delivery

#2634
20160220700
2016-08-04

Method to kill pathogenic microbes in a patient

#2635
20160220651
2016-08-04

Immunogenic tumor associated stromal cell antigen peptides and methods of their use

#2636
20160220641
2016-08-04

IL-1beta propeptide and IL-1Ra chimera and methods of using the same

#2637
20160220634
2016-08-04

Methods and compositions for modulating PD1

#2638
20160215259
2016-07-28

Method of preparing induced neural stem cells reprogrammed from non-neuronal cells using HMGA2

#2639
20160213753
2016-07-28

Methods for the treatment of neurological disorders and diseases using FNDC5

#2640
20160213746
2016-07-28

Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide

#2641
20160213745
2016-07-28

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

#2642
20160213741
2016-07-28

Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide

#2643
20160213740
2016-07-28

Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide

#2644
20160209425
2016-07-21

USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS

#2645
20160206693
2016-07-21

SRPX for treatment of cancer

#2646
20160206692
2016-07-21

Engineered integrin binding peptide compositions

#2647
20160206683
2016-07-21

Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide

#2648
20160206682
2016-07-21

Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide

#2649
20160201130
2016-07-14

MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE

#2650
20160200796
2016-07-14

Fusion protein comprising albumin and retinol-binding protein

#2651
20160200782
2016-07-14

Formulation of MK2 inhibitor peptides

#2652
20160200781
2016-07-14

Peptides and uses thereof

#2653
20160199461
2016-07-14

Treatment of synucleinopathies

#2654
20160199446
2016-07-14

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#2655
20160199445
2016-07-14

USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES

#2656
20160199444
2016-07-14

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases

#2657
20160199443
2016-07-14

Polypeptide targeting to mitochondria

#2658
20160195549
2016-07-07

Biomarkers for seizures

#2659
20160193292
2016-07-07

Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl

#2660
20160193251
2016-07-07

METHOD FOR TREATING ALS VIA THE INCREASED PRODUCTION OF FACTOR H

#2661
20160192677
2016-07-07

METHOD OF TREATING CORAL, A CORAL FOOD COMPOSITION AND A METHOD OF MANUFACTURE

#2662
20160185836
2016-06-30

Follistatin-related fusion proteins

#2663
20160184394
2016-06-30

Adeno-associated virus virions with variant capsid and methods of use thereof

#2664
20160177400
2016-06-23

RASAL1 is a major tumor suppressor gene in thyroid cancer

#2665
20160176980
2016-06-23

T-cell redirecting bispecific antibodies for treatment of disease

#2666
20160176968
2016-06-23

T-Cell Redirecting Bispecific Antibodies for Treatment of Disease

#2667
20160176936
2016-06-23

MPS peptides and use thereof

#2668
20160176935
2016-06-23

FILIP1L compositions and methods for treating cancer

#2669
20160175393
2016-06-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID SPHINGOLIPID AND CHOLESTEROL

#2670
20160175392
2016-06-23

DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS

#2671
20160168211
2016-06-16

Antibody multimerization technologies

#2672
20160166649
2016-06-16

Use of hepcidin as a regulator of iron homeostasis

#2673
20160166639
2016-06-16

Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

#2674
20160166638
2016-06-16

LACTOFERRIN-OSTEOPONTIN-IRON COMPLEX

#2675
20160166636
2016-06-16

Methods of treating chronic inflammatory diseases

#2676
20160159871
2016-06-09

Cyclic apelin derivatives for the treatment of heart failure

#2677
20160158381
2016-06-09

NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES

#2678
20160158315
2016-06-09

Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis

#2679
20160158314
2016-06-09

GLYCOSYLATED PROTEIN OF AN EXTRA-CELLULAR MATRIX FOR USE IN A METHOD OF TREATING AN ISCHEMIC HEART OF A HUMAN OR ANIMAL SUBJECT IN NEED THEREOF

#2680
20160158177
2016-06-09

Nutritional composition for improving brain function in phenylketonuria

#2681
20160152710
2016-06-02

Milk fat globule epidermal growth factor 8 regulates fatty acid uptake

#2682
20160151456
2016-06-02

LIPOPEPTIDE INHIBITORS OF RAS ONCOPROTEINS

#2683
20160151455
2016-06-02

Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use

#2684
20160151424
2016-06-02

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#2685
20160145312
2016-05-26

CETP antigenic peptide and fusion protein and their composition and applications

#2686
20160144054
2016-05-26

Vector(S) Containing an Inducible Gene Encoding a CDK4/CDK6 Inhibitor Useful for Treating Neurodegenerative Disorders or Diseases Associated with an Unscheduled Activation of the Cell Cycle

#2687
20160144002
2016-05-26

Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors

#2688
20160143994
2016-05-26

Myonectin (CTRP15), compositions comprising same, and methods of use

#2689
20160143992
2016-05-26

CLATHRIN THERAPEUTIC FOR PSYCHIATRIC and NEUROPSYCHIATRIC DISORDERS

#2690
20160137748
2016-05-19

ADAM22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease

#2691
20160136293
2016-05-19

Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides

#2692
20160136239
2016-05-19

Method for producing autologous proteins

#2693
20160136238
2016-05-19

BETA-CASEIN A2 AND REDUCING OR PREVENTING SYMPTOMS OF LACTOSE INTOLERANCE

#2694
20160136237
2016-05-19

NGAL AND URINARY TRACT INFECTION

#2695
20160130559
2016-05-12

Cell populations, methods of transdifferentiation and methods of use thereof

#2696
20160129079
2016-05-12

Semaphorin 3A for treatment of systemic lupus erythematosus

#2697
20160129051
2016-05-12

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#2698
20160129050
2016-05-12

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#2699
20160129049
2016-05-12

Purified amniotic membrane compositions and methods of use

#2700
20160129046
2016-05-12

Method and composition of inducing hair follicle neogenesis